GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Targeting PYK2 for the treatment of PDAC

$350,834
Jing Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Targeting PYK2 for the treatment of PDAC

$350,834
Jing Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

Role of ICAM1 in development and progression of pancreatic cancer

$350,834
Peter Storz · Mayo Clinic Jacksonville · R01 · FY2023 · CA

N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia

$350,748
Paul Joseph Grippo · University Of Illinois At Chicago · R01 · FY2016 · CA

Lipid storage and catabolism as drivers of metastatic invasion

$350,743
Gina Lynn Razidlo · Mayo Clinic Rochester · R01 · FY2024 · CA

Development of small molecule inhibitors of ULK1

$350,724
Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR

Core C: CODEX Core

$350,708
Garry P Nolan · Stanford University · P01 · FY2021 · CA

Modeling and targeting tumor-immune signaling interactions in tumor microenvironment

$350,626
Fuhai Li · Washington University · R01 · FY2023 · LM

Minor Endoscopic Sphincterotomy for Recurrent Acute Pancreatitis with Pancreas Divisum

$350,614
Gregory A Cote · Medical University Of South Carolina · U34 · FY2016 · DK

Function of TbRIII as a BMP Co-receptor in Human Cancer

$350,612
Gerard C Blobe · Duke University · R01 · FY2012 · CA

UPR Activators for Cancer Therapy

$350,560
Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2022 · CA

PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION

$350,558
Ju-Seog Lee · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION

$350,558
Ju-Seog Lee · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer

$350,540
Suresh T. Chari · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · DK

IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA

$350,460
Kian H Lim · Washington University · R37 · FY2023 · CA

Ras-mediated signals in human epithelial cell transformation and metastasis

$350,410
Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Dissection and manipulation of RB function

$350,219
Nicholas J Dyson · Massachusetts General Hospital · R01 · FY2014 · CA

Minimizing Uncertainty in Breast Ultrasound Imaging with Real-Time Coherence-Based Beamforming

$350,204
Muyinatu A. Lediju Bell · Johns Hopkins University · R01 · FY2025 · EB

Chemical genetic profiling of engineered tumor cells

$350,176
Brent R Stockwell · Columbia Univ New York Morningside · R01 · FY2015 · CA

Chemical genetic profiling of engineered tumor cells

$350,176
Brent R Stockwell · Columbia Univ New York Morningside · R01 · FY2013 · CA

Chemical genetic profiling of engineered tumor cells

$350,176
Brent R Stockwell · Columbia Univ New York Morningside · R01 · FY2016 · CA

Dissecting the Function of Cysteine Cathepsins in the Tumor Microenvironment

$350,170
Johanna Joyce · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA

Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit

$350,164
Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2016 · CA

Maturation of the Large Ribosomal Subunit in Yeast

$350,088
Arlen W Johnson · University Of Texas At Austin · R01 · FY2015 · GM

Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs

$350,016
Kevin J Yarema · Johns Hopkins University · R01 · FY2021 · CA